Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension

Respirology

Volumn 20, Issue 3, 2015, Pages 481-487

  Sadeghi, Saghar ^a   Granton, John T ^b   Akhavan, Pooneh ^c   Pasarikovski, Christopher R ^a   Roos, Adrienne M ^a   Thenganatt, John ^b   Moric, Jakov ^b   Johnson, Sindhu R ^a,b,d  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

connective tissue disease; idiopathic pulmonary arterial hypertension; pulmonary hypertension; rheumatoid arthritis; survival

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; PROSTAGLANDIN DERIVATIVE; WARFARIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG ARTERY PRESSURE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; WORLD HEALTH ORGANIZATION; COMPLICATION; EPIDEMIOLOGY; HYPERTENSION, PULMONARY; LUNG WEDGE PRESSURE; MIDDLE AGED; ONTARIO; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; TRENDS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; ONTARIO; PROPORTIONAL HAZARDS MODELS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84924577810     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12464     Document Type: Article

References (43)

1. Hyland RH, Gordon DA, Broder I, Davies GM, Russell ML, Hutcheon MA, Reid GD, Cox DW, Corey PN, Mintz S,. A systematic controlled study of pulmonary abnormalities in rheumatoid arthritis. J. Rheumatol. 1983; 10: 395-405.
2. Dawson JK, Goodson NG, Graham DR, Lynch MP,. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 2000; 39: 1320-1325.
3. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62: 2569-2581.
4. Johnson SR, Granton JT,. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. Eur Respir Rev 2011; 20: 277-286.
5. Johnson SR, Swiston JR, Swinton JR, Granton JT,. Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension. J. Rheumatol. 2008; 35: 1584-1590.
6. Johnson S, Gladman D, Urowitz M, Ibanez D, Granton J,. Pulmonary hypertension in systemic lupus. Lupus 2004; 13: 506-509.
7. Chow SL, Chandran V, Fazelzad R, Johnson SR,. Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension. Lupus 2012; 21: 353-364.
8. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, Miller DP, Nicolls MR, Zamanian RT,. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 2010; 138: 1383-1394.
9. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, et al. Definitions and diagnosis of pulmonary hypertension. J. Am. Coll. Cardiol. 2013; 62: D42-50.
10. Johnson SR, Granton JT, Tomlinson GA, Grosbein HA, Le T, Lee P, Seary ME, Hawker GA, Feldman BM,. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease. J. Rheumatol. 2012; 39: 276-285.
11. Gordon DA, Stein JL, Broder I,. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am. J. Med. 1973; 54: 445-452.
12. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA,. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin. Arthritis Rheum. 2004; 33: 231-238.
13. Keser G, Capar I, Aksu K, Inal V, Danaoʇlu Z, Savas R, Oksel F, Tunc E, Kabasakal Y, Kitapcioglu G, et al. Pulmonary hypertension in rheumatoid arthritis. Scand. J. Rheumatol. 2004; 33: 244-245.
14. Seyfeli E, Guler H, Akoglu S, Karazincir S, Akgul F, Saglam H, Seydaliyeva T, Yalcin F,. Right ventricular diastolic abnormalities in rheumatoid arthritis and its relationship with left ventricular and pulmonary involvement. A tissue Doppler echocardiographic study. Int. J. Cardiovasc. Imaging 2006; 22: 745-754.
15. Shariff N, Kumar A, Narang R, Malhotra A, Mukhopadhyaya S, Sharma SK,. A study of pulmonary arterial hypertension in patients with rheumatoid arthritis. Int. J. Cardiol. 2007; 115: 75-76.
16. Udayakumar N, Venkatesan S, Rajendiran C,. Pulmonary hypertension in rheumatoid arthritis-relation with the duration of the disease. Int. J. Cardiol. 2008; 127: 410-412.
17. Korkmaz C, Kaşifoglu T, Yaşar B,. Acceleration of left-ventricular diastolic dysfunction and pulmonary hypertension after TNF-alpha blocker. Ann. Pharmacother. 2005; 39: 1138-1139.
18. Castro GW, Appenzeller S, Bertolo MB, Costallat LT,. Isolated pulmonary hypertension secondary to rheumatoid arthritis. Clin. Rheumatol. 2006; 25: 901-903.
19. Onodera S, Hill JR,. Pulmonary hypertension. Report of a case in association with rheumatoid arthritis. Ohio State Med. J. 1965; 61: 141-144.
20. Baydur A, Mongan ES, Slager UT,. Acute respiratory failure and pulmonary arteritis without parenchymal involvement: demonstration in a patient with rheumatoid arthritis. Chest 1979; 75: 518-520.
21. Case Records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1992. A 68-year-old woman with rheumatoid arthritis and pulmonary hypertension. N. Engl. J. Med. 1992; 327: 873-880.
22. Kay JM, Banik S,. Unexplained pulmonary hypertension with pulmonary arteritis in rheumatoid disease. Br. J. Dis. Chest 1977; 71: 53-59.
23. Eaton AM, Serota H, Kernodle GW, Uglietta JP, Crawford J, Fulkerson WJ,. Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis. Am. J. Med. 1987; 82: 1039-1045.
24. Sharma S, Vaccharajani A, Mandke J,. Severe pulmonary hypertension in rheumatoid arthritis. Int. J. Cardiol. 1990; 26: 220-222.
25. Lehrman SG, Hollander RC,. Severe pulmonary hypertension in a patient with rheumatoid arthritis-response to nifedipine. West. J. Med. 1986; 145: 242-244.
26. Leeb BF, Scheinecker C, Schweitzer H, Smolen JS,. Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis. Br. J. Rheumatol. 1998; 37: 586-587.
27. Morikawa J, Kitamura K, Habuchi Y, Tsujimura Y, Minamikawa T, Takamatsu T,. Pulmonary hypertension in a patient with rheumatoid arthritis. Chest 1988; 93: 876-878.
28. Kawahara R, Takezawa J, Mike N, Fukui S, Nishimura M, Tachimori Y, Taenaka N, Yoshiya I,. Prostaglandin E1 in pulmonary hypertension of collagen disease. Crit. Care Med. 1987; 15: 884-885.
29. Balagopal VP, da Costa P, Greenstone MA,. Fatal pulmonary hypertension and rheumatoid vasculitis. Eur. Respir. J. 1995; 8: 331-333.
30. Seibold JR, Trontell MC,. Anticentromere antibody and primary pulmonary hypertension. J. Rheumatol. 1982; 9: 607-609.
31. Young ID, Ford SE, Ford PM,. The association of pulmonary hypertension with rheumatoid arthritis. J. Rheumatol. 1989; 16: 1266-1269.
32. Asherson RA, Morgan SH, Hackett D, Montanes P, Oakley C, Hughes GR,. Rheumatoid arthritis and pulmonary hypertension. A report of three cases. J. Rheumatol. 1985; 12: 154-159.
33. Skwarski K,. Pulmonary hypertension in a patient with pulmonary fibrosis and rheumatoid arthritis]. Pneumonol. Pol. 1985; 53: 151-155.
34. Tsuji M, Douwaki C, Yamada A, Nakura Y, Takahashi S, Hatano M, Sawada S, Nishinarita S, Ishikawa H,. Acute congestive heart failure due to malignant rheumatoid arthritis]. Kokyu to Junkan 1991; 39: 617-621.
35. Inoue T, Yamaguchi H, Hayashi T, Morooka S, Takabatake Y,. Right-to-left shunting through a patent foramen ovale caused by pulmonary hypertension associated with rheumatoid arthritis and Sjögren's syndrome: a case report. Angiology 1990; 41: 1082-1085.
36. Berizzo, EEA. [Rheumatoid arthritis and pulmonary hypertension]. Medicina (B Aires) 1990; 50: 553-556.
37. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am. J. Respir. Crit. Care Med. 2009; 179: 151-157.
38. Pope RM, Fletcher MA, Mamby A, Shapiro CM,. Rheumatoid arthritis associated with hyperviscosity syndrome and intermediate complex formation. Arch. Intern. Med. 1975; 135: 281-285.
39. Pope RM, Mannik M, Gilliland BC, Teller DC,. The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum. 1975; 18: 97-106.
40. Rietveld AP, van Paassen HC,. Monoclonal IgM rheumatoid factor in a patient with rheumatoid arthritis and hyperviscosity syndrome. Neth. J. Med. 1983; 26: 157-159.
41. Magliano M, Isenberg DA, Hillson J,. Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum. 2002; 46: 1997-2009.
42. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2009; 54: S43-54.
43. Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M,. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008; 58: 521-531.